Author response for "Empagliflozin reduces cardiorenal events, healthcare resource use and mortality in Sweden compared to dipeptidyl peptidase‐4 inhibitors: real world evidence from the Nordic <scp>EMPRISE</scp> study"

Thomas Nyström, Emilie Toresson Grip, Joel Gunnarsson, Paula Casajust, Kristina Karlsdotter, Josefin Skogsberg, Anastasia Ustyugova, Moe H. Kyaw, Maria Lajer, Gitte Mateusen, Lisette Koeneman, Neus Valveny, Emma Söreskog, Riho Klement, Fabian Hoti, EMPRISE Study Group

crossref(2022)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要